[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"lipid-profile\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:lipid-profile":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,44,67,111,139,169,204,233,267],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100640351","a-study-of-starting-strength-barbell-training-100640351",false,"NCT07578285","A Study Of Starting Strength Barbell Training","Effects Of Progressive Barbell Strength Training On Cardiovascular And Metabolic Health Markers","Inclusion Criteria:\n\n* Adults aged 18-100 years\n* Sedentary or minimally active (less than 150 minutes of moderate-intensity physical activity per week)\n* No participation in structured resistance training programs within the past 6 months.\n* Able to safely participate in resistance training as determined by medical screening\n* Willing to commit to 3 training sessions per week for 12 weeks\n* Able to provide informed consent\n* Willing to obtain pre- and post-intervention laboratory tests from the same laboratory company.\n\nExclusion Criteria:\n\n* Current participation in structured resistance training programs\n* Cardiovascular disease requiring activity restriction\n* Uncontrolled hypertension (systolic BP \\>180 mm Hg or diastolic BP \\>110 mm Hg)\n* Musculoskeletal conditions precluding safe barbell training\n* Changes in lipid-lowering or antihypertensive medications within 3 months prior to enrollment\n* Known cardiovascular, metabolic, or renal disease that would preclude safe participation in resistance training",true,"ALL","15 Years","100 Years",{"count":21,"type":22},200,"ESTIMATED","INTERVENTIONAL",[25],"NA","The purpose of this study is to determine the effect of a 12-week coached Starting Strength barbell training program on systolic and diastolic blood pressure.",[28,29,30],"Blood Pressure","Lipid Profile","Fasting Glucose","RECRUITING","2026-05-05",{"date":34,"type":35},"2026-05-11","ACTUAL",{"date":37,"type":22},"2026-06-01",{"date":39,"type":22},"2029-01-01",{"name":41,"class":42},"Mayo Clinic","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":48,"acronym":4,"eligibilityCriteria":49,"healthyVolunteers":16,"sex":17,"minAge":50,"maxAge":51,"enrollmentInfo":52,"targetDuration":4,"studyType":23,"phases":54,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":43},"100634019","hepatoprotective-effects-of-reishi-mushroom--ganoderma-lucidum-among-metabolic-dysfunction-associated-fatty-liver-disease-patients-100634019","NCT07534241","Hepatoprotective Effects of Reishi Mushroom- (Ganoderma Lucidum) Among Metabolic Dysfunction-associated Fatty Liver Disease Patients","Inclusion Criteria:\n\n* Adults aged 35-65 years\n* BMI between 18.5 and 30 kg\u002Fm².\n* Complete Blood Count test ranges, WBC \\\u003C 4,000-11,000 cells\u002FµL, RBC Men \\\u003C 4.5-6.0 \u002F Women 4.0-5.5 million\u002FµL, Hemoglobin: Men \\\u003C 13.5-17.5 \u002F Women 12.0-15.5 g\u002FdL, Platelets \\\u003C 150,000-450,000 cells\u002FµL.\n* Lipid profile test markers (elevated LDL, total cholesterol, or triglycerides less than 150mg\u002FdL high 200-499mg\u002FdL and 500 mg\u002FdL are above high.\n* Liver function test markers, ALT \\> 56 U\u002FL, AST\\>40 U\u002FL, ALP\\>147 UL.\n* Inflammatory markers: CRP \\>3 mg\u002FL, - IL-6 ≥3 pg\u002FmL, TNF-α ≥8 pg\u002FmL.\n* Elevated blood sugar levels, or hyperglycemia, refer to a typically above 126 mg\u002FdL, fasting or 200 mg\u002FdL post-meal.\n\nExclusion Criteria:\n\n* ● Diagnosed with severe cardiovascular disease, liver failure, or renal impairment.\n\n  * Pregnant or lactating women.\n  * Individuals currently on statins, ezetimibe, PCSK9 inhibitors, or any other lipid-lowering therapy.\n  * Allergic to mushrooms.\n  * Diagnosed with celiac disease or other chronic gastrointestinal disorders (e.g., Crohn's disease, ulcerative colitis).\n  * History of malignancy.\n  * Participation in another clinical trial within the last 3 months.","35 Years","65 Years",{"count":53,"type":22},102,[25],"This 12-week RCT investigates the hepatoprotective and immunomodulatory effects of Ganoderma lucidum combined with a probiotic-rich diet in adults with MAFLD, assessing liver enzymes, lipid profile, inflammation, gut microbiota, and oxidative stress.\n\nFindings are expected to show dose-dependent improvements in hepatic fat, insulin resistance, and inflammatory markers, potentially reducing reliance on pharmacotherapy in",[29,57],"Liver Biomarkers","2026-04-09",{"date":60,"type":35},"2026-04-16",{"date":62,"type":35},"2025-10-02",{"date":64,"type":22},"2026-04-15",{"name":66,"class":42},"University of Lahore",{"id":68,"slug":69,"hasResults":11,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":16,"sex":17,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":4,"studyType":79,"phases":4,"briefSummary":80,"conditions":81,"keywords":93,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":105,"completionDateStruct":107,"leadSponsor":109,"locationsCount":43},"100629594","expanded-studies-on-the-scapis-stockholm-reexamination-cohort-100629594","NCT07476703","Expanded Studies on the SCAPIS Stockholm Reexamination Cohort","Expanded Studies of Risk Factors for Pulmonary-, Liver-, and Cardiovascular Disease in the SCAPIS 2 Stockholm Reexamination","SCAPIS-ReEx","Inclusion Criteria: Subjects already included in the main \u002F general SCAPIS reexamination study in Stockholm.\n\nExclusion Criteria: Inability to provide consent.","56 Years","74 Years",{"count":78,"type":22},1400,"OBSERVATIONAL","The Swedish CArdioPulmonary bioImage Study (SCAPIS) is a unique, large-scale national research initiative involving 30,000 randomly selected individuals aged 50-64, recruited between 2014 and 2018. The study is a collaborative effort among six university hospitals across Sweden. A follow-up study, SCAPIS 2, is conducted for half of the original participants. In Stockholm, 2,500 individuals will be re-examined at Danderyd University Hospital and Karolinska Institutet.\n\nSCAPIS 2 includes a core set of examinations involving blood sampling, questionnaires, and imaging. In addition to these, complementary local investigations are conducted to enable more detailed research questions. This protocol describes the additional studies conducted in the Stockholm cohort. All complementary assessments aim to identify risk factors for current and future lung, liver, and cardiovascular diseases.:\n\nEXTENDED SAMPLING: Saliva and Blood Samples with Blood Cell Isolation. EXTENDED QUESTIONNAIRES: Dyspnea, Sleep, Respiratory Infections, and Dental Health.\n\nEXTENDED IMAGING AND PHYSIOLOGICAL MEASUREMENTS Cardiac Ultrasound and Abdominal Aortic Measurements. Liver Elastography. Vascular Stiffness by cuff-based pulse wave analysis and Photoplethysmography (PPG). Valvular and Vascular Calcification by CT imaging.",[82,83,84,85,86,87,88,89,29,90,91,92],"Coronary Artery Disease","Arterial Stiffness, Blood Pressure","AORTIC VALVE DISEASES","Mitral Valve Stenosis and\u002For Insufficiency","Heart Failure","Pulmonary Disease, Chronic Obstructive (COPD)","Steatohepatitis","Inflammation Biomarkers","Oral Microbiota","MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease","Metabolic Associated-dysfunction Steatohepatitis (MASH)",[94,95,96,97,98,99,100,101],"coronary artery disease","arterial stiffness","MASLD","COPD","inflammation","dyslipidemia","aortic aneurysm","oral microbiota","2026-03-12",{"date":104,"type":35},"2026-03-17",{"date":106,"type":35},"2024-04-08",{"date":108,"type":22},"2026-08-30",{"name":110,"class":42},"Danderyd Hospital",{"id":112,"slug":113,"hasResults":11,"nctId":114,"briefTitle":115,"officialTitle":116,"acronym":117,"eligibilityCriteria":118,"healthyVolunteers":16,"sex":17,"minAge":119,"maxAge":120,"enrollmentInfo":121,"targetDuration":4,"studyType":23,"phases":123,"briefSummary":125,"conditions":126,"keywords":4,"overallStatus":128,"whyStopped":4,"lastUpdateSubmitDate":129,"lastUpdatePostDateStruct":130,"startDateStruct":132,"completionDateStruct":134,"leadSponsor":136,"locationsCount":138},"100622028","phase-1-effects-of-selected-statins-on-blood-glucose-levels-in-healthy-volunteers-100622028","NCT07378293","Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers","Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers: A Randomized Phase I Clinical Trial","[Statins]","Inclusion Criteria:\n\n* healthy volunteers\n* Non diabetic\n* blood glucose level (less than140 mg\u002Fdl)\n\nExclusion Criteria:\n\n* Participants with a history of diabetes mellitus\n* With chronic diseases e.g heart disease, kidney disease\n* participants taking other medications","18 Years","55 Years",{"count":122,"type":22},100,[124],"PHASE1","This Phase I randomized clinical trial aims to investigate the short-term effects of three commonly prescribed statins (atorvastatin, rosuvastatin, and simvastatin) at different dose levels on blood glucose homeostasis in healthy volunteers. The study will assess changes in fasting blood glucose, insulin, and C-peptide levels following two days of statin administration under controlled conditions. The research seeks to provide comparative data on the potential diabetogenic effects of these medications.",[127,29],"Diabete Mellitus","NOT_YET_RECRUITING","2026-01-26",{"date":131,"type":35},"2026-01-30",{"date":133,"type":22},"2026-03-01",{"date":135,"type":22},"2027-02-20",{"name":137,"class":42},"Shaheed Benazir Bhutto University Sheringal Dir Upper",2,{"id":140,"slug":141,"hasResults":11,"nctId":142,"briefTitle":143,"officialTitle":144,"acronym":145,"eligibilityCriteria":146,"healthyVolunteers":16,"sex":17,"minAge":147,"maxAge":4,"enrollmentInfo":148,"targetDuration":4,"studyType":23,"phases":150,"briefSummary":151,"conditions":152,"keywords":157,"overallStatus":128,"whyStopped":4,"lastUpdateSubmitDate":161,"lastUpdatePostDateStruct":162,"startDateStruct":163,"completionDateStruct":165,"leadSponsor":167,"locationsCount":4},"100621023","open-space-and-closed-years-100621023","NCT07365228","Open Space and Closed Years","OPEN SPACE AND CLOSED YEARS","OS&CY","Inclusion Criteria:\n\n* physical fitness status which allows active participation in the physical exercising program organized as a tretment\n\nExclusion Criteria:\n\n* health conditions not allowing the participation in treatment program","50 Years",{"count":149,"type":22},150,[25],"The primary objective of this project is to examine the effects of a specific multicomponent physical activity program (MPAP), conducted in an outdoor setting, on the health and functional-motor status (HFMS) of women over the age of 60. Additionally, the study will investigate the influence of sociodemographic factors (SDF), physical literacy (PL), and health literacy (HL) on the baseline HFMS and the subsequent changes resulting from the KTP.\n\nStudy Methodology\n\nThe program participants will consist of older women (\\>60 years; n=60) whose current HFMS allows for participation in the exercise protocol. They will be divided into two groups:\n\nExperimental Group: Will participate in the MPAP.\n\nControl Group: Will not participate in the MPAP.\n\nThe exercise intervention (MPAP) will include a combination of aerobic activities, strength exercises, balance, and flexibility. It will be conducted two to three times per week across two three-month cycles, separated by a three-month break.\n\nData Collection and Environment Assessments: Sociodemographic factors, physical literacy, and health literacy will be measured at the start of the study. A series of HFMS indicators will be recorded before and after each exercise cycle.\n\nSetting: The MPAP will be performed outdoors in a public park.\n\nProject Significance Beyond analyzing the direct effects of the exercise program and the correlations between the measured variables, this project will contribute to a deeper understanding of the importance of the natural environment in implementing goal-oriented physical activity for the elderly population.",[153,154,29,155,156],"Physical Fitness","Health Literacy","Body Composition","Physical Literacy",[158,159,160],"physical fitness","health status","postmenopausal women","2026-01-15",{"date":129,"type":35},{"date":164,"type":22},"2026-01-01",{"date":166,"type":22},"2029-06-01",{"name":168,"class":42},"Goran Kuvacic",{"id":170,"slug":171,"hasResults":11,"nctId":172,"briefTitle":173,"officialTitle":174,"acronym":175,"eligibilityCriteria":176,"healthyVolunteers":11,"sex":17,"minAge":177,"maxAge":178,"enrollmentInfo":179,"targetDuration":4,"studyType":23,"phases":181,"briefSummary":182,"conditions":183,"keywords":191,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":195,"lastUpdatePostDateStruct":196,"startDateStruct":198,"completionDateStruct":200,"leadSponsor":202,"locationsCount":138},"100578896","how-a-mediterranean-diet-with-potatoes-impacts-heart-and-metabolic-health-in-adults-with-pre-diabetes-100578896","NCT06817252","How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes","Effects of a Mediterranean Dietary Pattern With White Potato on Cardiometabolic Health in Adults With Pre-Diabetes","MEDPOT-PREDM","Inclusion Criteria:\n\n* Men and postmenopausal women within the Las Vegas\u002FHenderson NV area\n* Ages 45-80 years\n* BMI between 25-40 kg\u002Fm2\n* HbA1c between 5.7-6.4%\n* Individuals from different demographic backgrounds (i.e., American Indian or Alaska Native, Caucasians, Asian, Black or African-American, Native Hawaiian, Hispanic, Latino or Pacific Islander)\n* Individuals who are considered \"non-frequent\" white potato consumers (\\\u003C2 servings of baked potatoes\u002Fweek)\n* Individuals from all races, genders, sexual identities, and religions will be included\n* Individuals must follow certain guidelines, including avoiding new medications during the study or significant changes to lifestyle factors (e.g. beginning to smoke or exercise more or less than usual)\n\nExclusion Criteria:\n\n* Individuals with uncontrolled hypertension (≥160\u002F100mmHg), active cancer, asthma, thyroid, kidney, liver, or pancreatic diseases\n* Individuals who are currently using insulin, on dialysis, changing\u002Fadding hypoglycemic, anti-hypertensive, and hypocholesterolemic medication within ≤3 months (or throughout the study)\n* Individuals participating in weight loss programs or another clinical trial\n* Individuals who start smoking\n* Individuals who have unstable metabolic or chronic diseases\n* Individuals who may have allergies to potatoes\n* Woman who are currently pregnant, think they may be pregnant, or who is nursing cannot participate (women must be postmenopausal)","45 Years","80 Years",{"count":180,"type":22},60,[25],"The goal of this clinical trial is to is to determine the effects of baked potato with the skin (BP) + nutrition education focused on adherence for a Mediterranean Dietary Pattern (MEDNE) on glycemic control, cardiometabolic health, and dietary quality in individuals with pre-diabetes from different demographic backgrounds. The main questions it aims to answer are:\n\n* Does BP+MEDNE contribute to improvements in indices of glycemic control, vascular function, blood lipids, inflammation\u002Foxidative stress, and body composition?\n* Does BP+MEDNE contribute to improvements to overall dietary intake and quality?\n\nResearchers will compare BP+MEDNE to MEDNE alone to see if BP+MEDNE can improve glycemic control, cardiometabolic health, and dietary quality in individuals with pre-diabetes from different demographic backgrounds.\n\nParticipants will:\n\n* Be asked to come to the study site initially for a Screening Study Visit to confirm eligibility.\n* Be asked to come the study site for a Pre-Baseline and Pre-12-Week Study Visit (one week prior to Baseline and 12-Week Study Visits) for placement of placement of a continuous glucose monitor and wearable devices to be removed at Baseline and 12-Week Study Visits.\n* Be asked to come to the study site for Baseline, 6- and 12-Week Study Visits for assessments of glycemic control and cardiometabolic health.\n* Be asked to complete 3-Day Food Records throughout the 12 week study period for assessment of dietary quality (5 total)\n* Receive pre-recorded MEDNE ( which can be accessed via computer device\u002Fipad\u002Fsmartphone) after Baseline and 6-Week Study Visits.\n* If randomized to the BP+MEDNE group, participants will receive pre-prepared baked potatoes with the skin for the 12-week study period (every 3 weeks) at Baseline and 6-Week Study Visits and asked to come to the study site for picking up the pre-prepared baked potatoes at weeks 3 and 9 of the study period.",[184,29,185,186,83,89,187,188,189,190],"Prediabetes","Hypertension","Glycemic Control","Dietary Quality","Body Composition Measurement","Waist Circumference","Anthropometrics: Height and Weight",[192,184,193,194,187],"White Potato","Mediterranean Diet","Cardiometabolic Health","2025-11-17",{"date":197,"type":35},"2025-11-20",{"date":199,"type":35},"2025-04-24",{"date":201,"type":22},"2026-12-31",{"name":203,"class":42},"University of Nevada, Las Vegas",{"id":205,"slug":206,"hasResults":11,"nctId":207,"briefTitle":208,"officialTitle":209,"acronym":210,"eligibilityCriteria":211,"healthyVolunteers":11,"sex":17,"minAge":119,"maxAge":4,"enrollmentInfo":212,"targetDuration":213,"studyType":79,"phases":4,"briefSummary":214,"conditions":215,"keywords":219,"overallStatus":128,"whyStopped":4,"lastUpdateSubmitDate":224,"lastUpdatePostDateStruct":225,"startDateStruct":227,"completionDateStruct":229,"leadSponsor":231,"locationsCount":43},"100604004","prognostic-impacts-of-lipid-profile-and-bmi-in-adult-aml-100604004","NCT07143877","Prognostic Impacts of Lipid Profile and BMI in Adult AML","Prognostic Impacts of Lipid Profile and Body Mass Index in Adult Acute Myeloid Leukemia Patients Treated With Intensive Induction Chemotherapy","AML\u002FBMI","Inclusion Criteria:\n\n* Adult patients (≥18yearsold) newly diagnosed with AML.\n* Patients eligible for intensive induction chemotherapy.\n* Patients who have given informed consent to participate in the study.\n\nExclusion Criteria:\n\n* Patients with secondary or relapsed AML.\n* Patients currently using lipid-lowering medications (e.g., statins).\n* Patients with known endocrine or metabolic disorders affecting BMI or lipid profile (e.g., uncontrolled diabetes, hypothyroidism, Cushing's syndrome).\n* Pregnant or lactating women.\n* Patients unwilling or unable to complete the study protocol.\n* Patients with M3 subtype of AML.",{"count":21,"type":22},"35 Days","The goal of this observational study is to evaluate the changes in lipid profile parameters (total cholesterol, triglycerides, HDL-C, and LDL-C) in adult AML patients before and after intensive induction chemotherapy. The main questions it aims to answer are:\n\n* Are there correlations between metabolic changes (in lipid profile and BMI) and treatment outcomes, including remission status and incidence of chemotherapy-related complications?\n* Can the baseline lipid profile and BMI serve as prognostic markers for response to induction chemotherapy.?\n\nParticipants will be observed before and after induction chemotherapy regarding their lipid profile, and BMI, observing any correlations between the different results with any complications, and with remission status.",[216,217,29,218],"AML (Acute Myeloid Leukemia)","BMI","Induction Chemotherapy",[220,217,221,222,223],"AML","Lipid profile","Adult","Induction chemotherapy","2025-08-23",{"date":226,"type":35},"2025-08-27",{"date":228,"type":22},"2025-11-15",{"date":230,"type":22},"2027-03-15",{"name":232,"class":42},"Assiut University",{"id":234,"slug":235,"hasResults":11,"nctId":236,"briefTitle":237,"officialTitle":237,"acronym":4,"eligibilityCriteria":238,"healthyVolunteers":16,"sex":17,"minAge":119,"maxAge":239,"enrollmentInfo":240,"targetDuration":4,"studyType":23,"phases":242,"briefSummary":243,"conditions":244,"keywords":249,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":258,"lastUpdatePostDateStruct":259,"startDateStruct":261,"completionDateStruct":263,"leadSponsor":265,"locationsCount":138},"100582272","pulses-optimizing-pulse-consumption-for-cardiometabolic-health-100582272","NCT06861153","Pulses: Optimizing Pulse Consumption for Cardiometabolic Health","Inclusion Criteria:\n\n* ≥ 18 years old (with no upper age limit)\n* Currently consuming less than 1.5 cup-equivalents of pulses per week\n* Willing and able to participate in a 12-week dietary intervention focused on increased pulse consumption\n* Able to communicate in English and provide written informed consent\n* Assessed as suitable to participate in a nutrition intervention by the study dietitian or primary healthcare provider\n\nExclusion Criteria:\n\n* Individuals already consuming \\>150 minutes\u002Fweek of pulse-based dietary programming or otherwise regularly meeting high pulse intake benchmarks at baseline\n* Patients with food allergies or intolerances that preclude the consumption of pulses\n* Individuals who have not received clearance from their healthcare provider to make significant dietary modifications\n* Participants anticipating major changes in dietary habits due to elective surgery, planned relocation, or other lifestyle alterations during the study period (12 weeks)","75 Years",{"count":241,"type":22},180,[25],"This randomized clinical trial aims to evaluate the effects of consuming two different doses of pulses (1.5 cups\u002Fweek or 3 cups\u002Fweek) in individuals with baseline intake below 1.5 cups\u002Fweek, compared to a control group receiving standard nutrition education based on the United States Department of Agriculture's (USDA) My Plate guidelines.\n\nThe main question the Pulses study aims to answer is:\n\n• What is the effect of increasing pulse consumption (in a dose-response manner) on specific cardiometabolic risk factors, including LDL-C, CRP, HBA1C, and blood pressure compared to standard nutrition education?\n\nFor secondary outcomes, this study aims to answer the following:\n\n• Does increased pulse consumption improve the following: overall serum lipid profile (Total cholesterol (TC), HDL-C, Triglycerides (TG), diet quality (measured by the Healthy Eating Index), and participants self-reported satisfaction with life (SWLS) and Satisfaction with Food-related Life (SWFoL).\n\nAll participants will attend biweekly classes and food demonstrations. The pulses groups will learn to prepare various pulse-based recipes, while the control group will receive guidance on preparing healthy meals following the USDA MyPlate recommendations.",[245,246,247,29,248],"Cardiovascular (CV) Risk","Healthy Eating Index","HbA1c","CRP",[250,251,252,253,254,255,256,257],"pulses","pulse consumption","cardiometabolic health","dietary intervention","nutrition education","chronic disease prevention","healthy eating","dietary guidelines","2025-08-18",{"date":260,"type":35},"2025-08-19",{"date":262,"type":35},"2025-07-01",{"date":264,"type":22},"2028-09-01",{"name":266,"class":42},"University of Arizona",{"id":268,"slug":269,"hasResults":11,"nctId":270,"briefTitle":271,"officialTitle":271,"acronym":4,"eligibilityCriteria":272,"healthyVolunteers":11,"sex":273,"minAge":274,"maxAge":275,"enrollmentInfo":276,"targetDuration":4,"studyType":23,"phases":278,"briefSummary":279,"conditions":280,"keywords":4,"overallStatus":128,"whyStopped":4,"lastUpdateSubmitDate":284,"lastUpdatePostDateStruct":285,"startDateStruct":287,"completionDateStruct":289,"leadSponsor":291,"locationsCount":43},"100566704","ultrasound-lipolysis-versus-cryolipolysis-on-lipid-profile-levels-in-centrally-obese-middle-aged-men-100566704","NCT06658639","Ultrasound Lipolysis Versus Cryolipolysis On Lipid Profile Levels In Centrally Obese Middle Aged Men","Inclusion Criteria:\n\n1. Obese men with middle age range will be 40-60 years.\n2. Obese men with central obesity.\n3. Body mass index (BMI) greater than 30 Kg \\\\m2.\n4. Waist circumference will be \\>94 cm.\n5. Waist to hip ratio more than 0.9\n\nExclusion Criteria:\n\n1. Chronic respiratory disorders and cardiovascular problems.\n2. Diabetic patients.\n3. Presence of skin diseases in abdominal regions that prevent the use of ultra sound or cryolipolysis therapy.\n4. Men with kidney or liver diseases.\n5. Tumor diseases\n6. Lesions of higher center leading to obesity.\n7. History of active or chronic infectious, autoimmune disease.\n8. History of abdominal surgeries.","MALE","40 Years","60 Years",{"count":277,"type":22},66,[25],"The study compares the effects of ultrasound lipolysis and cryo lipolysis on cholesterol, triglyceride, high density lipoprotein, low density lipoprotein, body mass index, skin thickness, waist circumference, and waist hip ratio in centrally obese middle aged men. It also investigates the impact of ultrasound lipolysis on skin thickness, waist circumference, and waist hip ratio.",[281,282,29,283],"Ultrasound Lipolysis","Cryolipolysis","Central Obesity","2024-10-24",{"date":286,"type":35},"2024-10-26",{"date":288,"type":22},"2024-11-05",{"date":290,"type":22},"2025-04-05",{"name":292,"class":42},"Cairo University"]